Efficacy and safety of different doses of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A systematic review.

Authors
Category Systematic review
JournalChinese Journal of Evidence-Based Medicine
Year 2008
This article has no abstract
Epistemonikos ID: afd9eb865a35fdb578b2d745518e446b5007b9ec
First added on: Apr 03, 2019